US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

272.07

-0.3100-0.11%

Post-market: 272.300.2300+0.08%18:47 EDT

Volume:61.74K

Turnover:16.80M

Market Cap:2.95B

PE:31.84

High:273.14

Open:271.38

Low:270.78

Close:272.38

52wk High:273.14

52wk Low:171.06

Shares:10.85M

Float Shares:10.85M

Volume Ratio:0.74

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:2.22

PE(LYR):7.21

Loading ...

Overview Company News Filings

Neogenomics Inc : Needham Raises Target Price to $19 from $15

THOMSON REUTERS

Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $150 from $135

THOMSON REUTERS

Alkermes Plc : Jefferies Raises Target Price to $72 from $65

THOMSON REUTERS

Alkermes Plc : TD Cowen Raises Target Price to $58 from $57

THOMSON REUTERS

Alkermes Plc : Baird Raises Target Price to $58 from $48

THOMSON REUTERS

Neogenomics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Veracyte to Present at Canaccord Genuity Growth Conference Fireside Chat

Neogenomics Shares Rise 6.5% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS

NeoGenomics Q2 FY26 Adjusted Ebitda Climbs 36% to $14 Million; Revenue Rises 11% to $202 Million

NeoGenomics Q2 Revenue USD 202 Million Vs. IBES Estimate USD 197 Million

Neogenomics Inc: Decrease in Operating Expenses for Q2 2026 was Primarily Due to $20 Mln of Impairment Charges Taken in Q2 2025

THOMSON REUTERS

Neogenomics Q2 Operating Expenses USD 102 Million

THOMSON REUTERS

Neogenomics: Sees Fy2026 Adj Ebitda $56 Mln to $58 MLN\n

THOMSON REUTERS

Neogenomics: Expects Fy2026 Net Loss of $42 Mln to $34 MLN\n

THOMSON REUTERS

Neogenomics Q2 Adjusted Ebitda USD 14 Million

THOMSON REUTERS

Neogenomics Reports Second Quarter 2026 Results

THOMSON REUTERS

Veracyte to Participate in Upcoming Investor Conferences

Wall Street Analysts Are Bullish on Top Healthcare Picks

Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/FBT/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":272.07,"timestamp":1787774400000,"preClose":272.38,"halted":0,"volume":61744,"hourTrading":{"tag":"盘后","latestPrice":272.3,"preClose":272.07,"latestTime":"18:47 EDT","volume":32,"amount":8709.9392,"timestamp":1787784461908,"change":0.23,"changeRate":0.000845,"amplitude":0.000845},"delay":0,"changeRate":-0.0011381158675380068,"floatShares":10850002,"shares":10850002,"eps":8.545272,"marketStatus":"Post-Mkt","change":-0.31,"latestTime":"08-26 19:07:51 EDT","open":271.38,"high":273.14,"low":270.7821,"amount":16796342.573119998,"amplitude":0.008657,"askPrice":275,"askSize":13,"bidPrice":270.27,"bidSize":200,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":272.38,"sharesOutstanding":11450002,"nav":269.14,"aum":2920169538.28,"bidAskSpread":0.00091,"preHourTrading":{"tag":"盘前","latestPrice":272.38,"preClose":272.38,"latestTime":"08:15 EDT","volume":2,"amount":544.76,"timestamp":1787746518358,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":272.3,"preClose":272.07,"latestTime":"18:47 EDT","volume":32,"amount":8709.9392,"timestamp":1787784461908,"change":0.23,"changeRate":0.000845,"amplitude":0.000845},"volumeRatio":0.740734,"impliedVol":0.2406,"impliedVolPercentile":0.8924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10850002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":0.740734,"shares":10850002,"dividePrice":0,"high":273.14,"amplitude":0.008657,"preClose":272.38,"low":270.7821,"week52Low":171.0601,"pbRate":"2.22","psRate":"1086.92","week52High":273.14,"institutionHeld":0,"latestPrice":272.07,"committee":0.877934,"eps":8.545272,"divideRate":0,"volume":61744,"delay":0,"ttmEps":8.545272,"open":271.38,"prevYearClose":206.52,"prevWeekClose":270.9465,"prevMonthClose":245.06,"prevQuarterClose":247.89,"fiveDayClose":271.87,"twentyDayClose":250.47,"sixtyDayClose":220.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655649208","title":"Neogenomics Inc : Needham Raises Target Price to $19 from $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2655649208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655649208?lang=en_us&edition=fundamental","pubTime":"2026-07-29 19:07","pubTimestamp":1785323273,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V1F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NEO","BK4196","FBT","LU0106261612.USD","LU0012050646.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655856718","title":"Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $150 from $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2655856718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655856718?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:51","pubTimestamp":1785304262,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1559883803.SGD","BK4532","CORT","LU0566484027.USD","PSCH","BK4007","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655385647","title":"Alkermes Plc : Jefferies Raises Target Price to $72 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2655385647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655385647?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:45","pubTimestamp":1785303957,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBT","MEDX","PSIL","PSCH","IBRN","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655855711","title":"Alkermes Plc : TD Cowen Raises Target Price to $58 from $57","url":"https://stock-news.laohu8.com/highlight/detail?id=2655855711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655855711?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:22","pubTimestamp":1785302541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0HB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","IBRN","MEDX","ALKS","FBT","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655853939","title":"Alkermes Plc : Baird Raises Target Price to $58 from $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2655853939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655853939?lang=en_us&edition=fundamental","pubTime":"2026-07-29 12:22","pubTimestamp":1785298959,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V062:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","PSCH","MEDX","BK4139","PSIL","IBRN","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655839082","title":"Neogenomics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2655839082","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655839082?lang=en_us&edition=fundamental","pubTime":"2026-07-29 08:07","pubTimestamp":1785283662,"startTime":"0","endTime":"0","summary":"Neogenomics Inc reports results for the quarter ended June 30 - Earnings SummaryNeogenomics IncNEO.OQreported quarterly adjusted earnings of 5 cents per share for the quarter ended June 30, higher tha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL8N43V00B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","FBT","BK4196","LU0012050646.USD","LU0106261612.USD","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655880040","title":"Veracyte to Present at Canaccord Genuity Growth Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2655880040","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655880040?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:27","pubTimestamp":1785270434,"startTime":"0","endTime":"0","summary":"Veracyte to present at Canaccord Genuity Growth Conference fireside chatVeracyte will attend the Canaccord Genuity 46th Annual Growth Conference in Boston on Aug. 11, featuring a 10:30 a.m. ET firesid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL9zWctP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875086.SGD","LU0912757837.SGD","LU1548497426.USD","LU2111349929.HKD","LU2357305700.SGD","LU1720051108.HKD","BK4516","LU2089283258.USD","LU1720051017.SGD","BK4504","LU0210528500.USD","LU1162221912.USD","IAI","LU1989772840.SGD","LU0390134368.USD","LU0053666078.USD","KBWB","LU2347655156.SGD","LU0106831901.USD","BK4581","LU0267386448.USD","LU0528227936.USD","LU2133065610.SGD","LU1064131342.USD","BK4534","LU1244550221.USD","LU0795875169.SGD","LU1791710400.SGD","LU1989772923.USD","LU2271345857.HKD","LU0971096721.USD","LU1668664300.SGD","LU2089284900.SGD","LU0006306889.USD","LU0882574139.USD","BK4127","LU0106261372.USD","FBT","LU1363072403.SGD","LU2023251221.USD","LU0225283273.USD","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU0320765646.SGD","LU1074936037.SGD","LU1791710582.SGD","LU1988902786.USD","BK4585","VCYT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655288055","title":"Neogenomics Shares Rise 6.5% in Extended Trading After Posting Quarterly Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2655288055","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655288055?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:15","pubTimestamp":1785269721,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL6N43U19X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0012050646.USD","LU0106261612.USD","BK4121","BK4196","FBT","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655288705","title":"NeoGenomics Q2 FY26 Adjusted Ebitda Climbs 36% to $14 Million; Revenue Rises 11% to $202 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655288705","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655288705?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:09","pubTimestamp":1785269346,"startTime":"0","endTime":"0","summary":"NeoGenomics Q2 FY26 adjusted EBITDA climbs 36% to $14 million; revenue rises 11% to $202 millionNeoGenomics posted Q2 2026 revenue of $202 million, up 11% year over year.Adjusted EBITDA climbed 36% to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL42J9VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LU0012050646.USD","BK4121","LU0106261612.USD","FBT","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655780887","title":"NeoGenomics Q2 Revenue USD 202 Million Vs. IBES Estimate USD 197 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655780887","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655780887?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:06","pubTimestamp":1785269161,"startTime":"0","endTime":"0","summary":"BRIEF-NeoGenomics Q2 Revenue USD 202 Million Vs. IBES Estimate USD 197 MillionJul 28 (Reuters) - NeoGenomics Q2 adjusted EBITDA USD 14 million.Q2 operating expenses USD 102 millionQ2 adjusted net income USD 7 millionQ2 gross profit USD 92 millionQ2 net income USD 2 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX2GZQJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","FBT","NEO","LU0106261612.USD","BK4121","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655988083","title":"Neogenomics Inc: Decrease in Operating Expenses for Q2 2026 was Primarily Due to $20 Mln of Impairment Charges Taken in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2655988083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655988083?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX2GZQJX:12","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NEO","FBT","BK4121","LU0106261612.USD","BK4196","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655872548","title":"Neogenomics Q2 Operating Expenses USD 102 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655872548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655872548?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX2GZQJX:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NEO","FBT","BK4196","BK4121","LU0106261612.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655746887","title":"Neogenomics: Sees Fy2026 Adj Ebitda $56 Mln to $58 MLN\\n","url":"https://stock-news.laohu8.com/highlight/detail?id=2655746887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655746887?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX2GZQJX:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","FBT","NEO","LU0106261612.USD","BK4121","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655704887","title":"Neogenomics: Expects Fy2026 Net Loss of $42 Mln to $34 MLN\\n","url":"https://stock-news.laohu8.com/highlight/detail?id=2655704887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655704887?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX2GZQJX:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0012050646.USD","BK4121","FBT","NEO","LU0106261612.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655450887","title":"Neogenomics Q2 Adjusted Ebitda USD 14 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655450887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655450887?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nPLX2GZQJX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU0106261612.USD","LU0012050646.USD","FBT","BK4196","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655887147","title":"Neogenomics Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2655887147","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655887147?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUAK3WCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","NEO","BK4121","LU0012050646.USD","LU0106261612.USD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655836870","title":"Veracyte to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2655836870","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655836870?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269100,"startTime":"0","endTime":"0","summary":"Kelly Gura. investors@veracyte.com. Media:. Molly Cornbleet. media@veracyte.com. +1-650-351-8780","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/28/3334706/0/en/Veracyte-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655884804","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2655884804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655884804?lang=en_us&edition=fundamental","pubTime":"2026-07-29 02:00","pubTimestamp":1785261615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Incyte (INCY) with bullish senti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-264?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-264?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","FBT","INCY","PSCH","IBRN","PSIL","BK4585","IDNA","MEDX","BK4139","ALKS","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655264886","title":"Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2655264886","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655264886?lang=en_us&edition=fundamental","pubTime":"2026-07-29 00:10","pubTimestamp":1785255000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","IBRN","FBT","PSCH","MEDX","ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654424888","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654424888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654424888?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:20","pubTimestamp":1785248424,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS) and Universal Health (UHS). Alkermes (ALKS) Needh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LABU","XBI","PSCH","XLV","BK4585","BK4139","HCSG","ALKS","BK4185","PSIL","LU0029874061.USD","UHS","BK4588","IBRN","MEDX","LU0128526141.USD","FBT","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}